Loading...
•
Jun 30, 2022
Mesa Labs Q1 2023 Earnings Report
Mesa Labs reported a revenue increase of 44% but experienced a decrease in operating and net income for Q1 2023.
Key Takeaways
Mesa Labs announced its Q1 2023 results, revealing a 44% increase in revenues compared to the same quarter in the prior year. However, the company's operating income decreased by 247%, and net loss was $(1,438,000), a decrease of 172%. The results were impacted by headwinds from China lockdowns, FX, and continued operational constraints caused by both materials and labor shortages.
Revenues increased by 44% compared to the same quarter in the prior year, reaching $50,453,000.
Operating income decreased by 247% to $(4,594,000).
Net loss was $(1,438,000), a 172% decrease, resulting in a loss of $(0.27) per diluted share.
Organic revenue growth was 3%, but would have been 6% assuming consistent FX rates as in 1Q22.
Mesa Labs
Mesa Labs
Mesa Labs Revenue by Segment
Revenue by Segment
Sterilization & Disinfection Control Revenue
CapyFin.comBiopharmaceutical Development Revenue
CapyFin.comCalibration Solutions Revenue
CapyFin.comClinical Genomics Revenue
CapyFin.com Forward Guidance
Turbulence in the macroeconomic environment impacting FX, material prices, labor costs, and customer activity will present a challenging operating environment throughout the year and perhaps longer.
Positive Outlook
- Retain a strong belief in our served markets.
- Believe in the power of our distinct solutions.
- Believe in the ability of our team to navigate the challenges ahead.
Challenges Ahead
- Turbulence in the macroeconomic environment impacting FX.
- Turbulence in the macroeconomic environment impacting material prices.
- Turbulence in the macroeconomic environment impacting labor costs.
- Turbulence in the macroeconomic environment impacting customer activity.
- Challenging operating environment throughout the year and perhaps longer.
Revenue & Expenses
Visualization of income flow from segment revenue to net income